The Neuroimmunology/Multiple Sclerosis Program in the Department of Neurology at Indiana University School of Medicine provides multidisciplinary care for individuals with multiple sclerosis and disorders of the central nervous system. The program coordinates care from neurologic, nursing, psychological, physical therapy, rehabilitation and urologic perspectives.
Clinical care incorporates the use of newer maintenance immunotherapies, including interferon-beta and glatiramer acetate as well as new symptomatic treatments, including intrathecal baclofen for spasticity and robotic therapy.
The Neuroimmunology/Multiple Sclerosis research program participates in investigational new drug studies; some trials are single-site studies at IU School of Medicine and others are part of national and international multicenter consortiums.
